132 related articles for article (PubMed ID: 3053904)
1. HLA-B27 in inbred and non-inbred transgenic mice. Cell surface expression and recognition as an alloantigen in the absence of human beta 2-microglobulin.
Taurog JD; Lowen L; Forman J; Hammer RE
J Immunol; 1988 Dec; 141(11):4020-3. PubMed ID: 3053904
[TBL] [Abstract][Full Text] [Related]
2. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the HLA-Cw3-specific cytotoxic T lymphocyte response of HLA-B7 X human beta 2m double transgenic mice.
Barra C; Pérarnau B; Gerlinger P; Lemeur M; Gillet A; Gibier P; Lemonnier FA
J Immunol; 1989 Nov; 143(10):3117-24. PubMed ID: 2478616
[TBL] [Abstract][Full Text] [Related]
4. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
[TBL] [Abstract][Full Text] [Related]
5. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition.
Kievits F; Boerenkamp WJ; Lokhorst W; Ivanyi P
J Immunol; 1990 Jun; 144(12):4513-9. PubMed ID: 2351823
[TBL] [Abstract][Full Text] [Related]
6. HLA-restricted recognition of viral antigens in HLA transgenic mice.
Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice expressing human HLA and CD8 molecules generate HLA-restricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection.
Tishon A; LaFace DM; Lewicki H; van Binnendijk RS; Osterhaus A; Oldstone MB
Virology; 2000 Sep; 275(2):286-93. PubMed ID: 10998329
[TBL] [Abstract][Full Text] [Related]
8. Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression.
Kingsbury DJ; Mear JP; Witte DP; Taurog JD; Roopenian DC; Colbert RA
Arthritis Rheum; 2000 Oct; 43(10):2290-6. PubMed ID: 11037889
[TBL] [Abstract][Full Text] [Related]
9. Cell surface expression and alloantigenic function of a human class I MHC heavy chain gene (HLA-B7) in transgenic mice.
Chamberlain JW; Nolan JA; Gromkowski SH; Kelley KA; Eisenstadt JM; Herrup K; Janeway CA; Weissman SM
J Immunol; 1988 Feb; 140(4):1285-92. PubMed ID: 3125253
[TBL] [Abstract][Full Text] [Related]
10. [Immunological function of HLA-DQw6 molecules expressed in DQw6 transgenic C57BL/6 mice].
Inamitsu T
Fukuoka Igaku Zasshi; 1991 Feb; 82(2):59-70. PubMed ID: 2022362
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element.
Le AX; Bernhard EJ; Holterman MJ; Strub S; Parham P; Lacy E; Engelhard VH
J Immunol; 1989 Feb; 142(4):1366-71. PubMed ID: 2464645
[TBL] [Abstract][Full Text] [Related]
12. Expression of human HLA-B27 transgene alters susceptibility to murine Theiler's virus-induced demyelination.
Rodriguez M; Nickerson C; Patick AK; David CS
J Immunol; 1991 Apr; 146(8):2596-602. PubMed ID: 2016520
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of H-2-restricted CTL responses and efficient recognition of HLA-A3 molecules in DBA/2 HLA/A24 responder mice.
Barra C; Gournier H; Garcia Z; Marche PN; Jouvin-Marche E; Briand P; Fillipi P; Lemonnier FA
J Immunol; 1993 May; 150(9):3681-9. PubMed ID: 7682582
[TBL] [Abstract][Full Text] [Related]
14. Abnormal anti-viral immune response in mice is corrected in HLA-B27.2-transgenic mice.
Kievits F; Lokhorst W; Ivanyi P
Eur J Immunol; 1990 May; 20(5):1189-92. PubMed ID: 1694133
[TBL] [Abstract][Full Text] [Related]
15. Strong xenogeneic HLA response in transgenic mice after introducing an alpha 3 domain into HLA B27.
Kalinke U; Arnold B; Hämmerling GJ
Nature; 1990 Dec; 348(6302):642-4. PubMed ID: 1701221
[TBL] [Abstract][Full Text] [Related]
16. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
Galocha B; López D; López de Castro JA
J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
[TBL] [Abstract][Full Text] [Related]
17. Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface.
Carreno BM; Hansen TH
Eur J Immunol; 1994 Jun; 24(6):1285-92. PubMed ID: 8206088
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE
J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides.
Khare SD; Bull MJ; Hanson J; Luthra HS; David CS
J Immunol; 1998 Jan; 160(1):101-6. PubMed ID: 9551961
[TBL] [Abstract][Full Text] [Related]
20. Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice.
Kuon W; Lauster R; Böttcher U; Koroknay A; Ulbrecht M; Hartmann M; Grolms M; Ugrinovic S; Braun J; Weiss EH; Sieper J
Arthritis Rheum; 1997 May; 40(5):945-54. PubMed ID: 9153558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
